Andere Sprachen CRISPR Therapeutics AG

Aktien

A2AT0Z

CH0334081137

CRSP

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 28.05.2024			% 5 Tage	% 1. Jan.
54,84 ^USD	-0,72 %		+0,15 %	-12,40 %

23.05.	CRISPR Therapeutics ernennt Naimish Patel zum Chief Medical Officer und befördert Julianne Bruno zum Chief Operating Officer	MT
23.05.	CRISPR Therapeutics kündigt Änderungen in der Geschäftsführung an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer	23.05.
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments	23.05.
CRISPR Therapeutics Announces Executive Changes	23.05.
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference	09.05.
CRISPR Therapeutics AG Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Reports Q1 Revenue $504,000	08.05.
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	08.05.
CRISPR Therapeutics : ASGCT 2024 Oral Presentation	08.05.
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach	08.05.
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing in Vivo Gene Editing Approach	08.05.
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene and Cell Therapy 2024 Annual Meeting	23.04.
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	22.04.
Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing	17.04.
Harvard University: How to realize immense promise of gene editing	17.04.
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference	03.04.
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	01.04.
Recent Appellate Decision Overturns Revocations Of Broad Institute CRISPR-Cas9 Patents	26.03.
CRISPR Therapeutics Proposes New Appointment to the Board of Directors	13.03.
CRISPR Therapeutics Swings to Q4 Profit, Revenue Increases	21.02.
CRISPR Therapeutics AG Reports Earnings Results for the Full Year Ended December 31, 2023	21.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CRISPR Therapeutics AG

Aktien

A2AT0Z

CH0334081137

CRSP

Andere Sprachen

Filter